Alkemy

AGM Information • Mar 29, 2024

Alkemy S.p.A.

Registered office in Milan, at via San Gregorio 34, Milan - share capital resolved Euro 632,467.00, Euro 595,534.32 subscribed and paid-up

Registration number with Milan Companies House, tax code and VAT number 05619950966 - Economic and Administrative Index (REA) no. 1835268

Explanatory Report by the directors on the first item on the agenda of the shareholders' meeting in ordinary session convened for 29 April 2024, in ordinary and extraordinary session and at single call.

Item 1 on the agenda - Approval of the Financial Statements as of December 31st, 2023, accompanied by the Directors' Report on Operations, the Report of the Board of Auditors and the Independent Auditors' Report. Presentation of the Consolidated Financial Statements as of December 31st, 2023 and of the Consolidated Non-Financial Statement prepared in accordance with Italian Legislative Decree no. 254/2016.

Shareholders,

As regards the first item on the agenda of the Shareholders' Meeting convened for this coming April, 29th 2024, please examine the Company's Annual Financial Report at 31 December 2023, approved by the Alkemy Board of Directors on March, 28th 2024 and which contains the draft Financial Statements for the Company and the consolidated financial statements, together with the Report by the Board of Directors on Operations and the certification pursuant to Art. 154-bis, paragraph 5, of Italian Legislative Decree no. 58 of 24 February 1998, as subsequently amended and supplemented.

On March, 28th 2024, the Board of Directors also approved, in a separate report to the Report by the Board of Directors on Operations, the Consolidated Non-Financial Statement prepared in accordance with Italian Legislative Decree no. 254/2016.

This documentation will be made available to the public in accordance with the terms and conditions of the law, as will the Report by the Board of Auditors and the Independent Auditors' Report.

It is recalled that the Company's consolidated financial statements at 31 December 2023, which report a consolidated net period profit of Euro 3,535 thousand, as well as the consolidated non-financial statement prepared in accordance with Italian Legislative Decree 254/2016, are submitted for your examination but do not require the approval of the Company's Shareholders' Meeting.

In referring to these documents, we would ask you to kindly approve the Financial Statements at 31 December 2023, which close with a net period profit of Euro 4,424,636 and propose the following resolution be passed:

"The Shareholders' Meeting of Alkemy S.p.A.

• having examined the Report by the Board of Directors on Operations;
• having acknowledged the report by the Board of Auditors and by the independent auditing firm KPMG S.p.A.;
• having acknowledged the consolidated financial statements at 31 December 2023, which report a consolidated net period profit of Euro 3,535 thousand;
• having acknowledged the consolidated non-financial statement prepared in accordance with Italian Legislative Decree 254/2016;
• having examined the Financial Statements at 31 December 2023, in the draft presented by the Board of Directors, reporting a net period profit of Euro 4,424,636;

resolved

• 1. to approve, both as a whole and in its individual items, the Financial Statements at 31 December 2023, comprising the Balance Sheet, Income Statement, Statement of Changes in Equity, Statement of Cash Flows and Notes, as presented to the Board of Directors, which record a net period profit of Euro 4,424,636;
• 1. to confer upon the Chairman of the Board of Directors and the Chief Executive Officer - also through special proxies and/or delegated representatives - a mandate to act in all ways relevant, consequent or related to the implementation of the resolution pursuant to point 1) above.".

Milan, March 28th, 2024

For the Board of Directors

The Chairman, Alessandro Mattiacci